Public Employees Retirement System of Ohio Makes New $46.39 Million Investment in Danaher Corporation $DHR

Public Employees Retirement System of Ohio bought a new position in Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 243,556 shares of the conglomerate’s stock, valued at approximately $46,393,000.

A number of other large investors have also made changes to their positions in the company. EP Wealth Advisors LLC acquired a new position in Danaher during the second quarter valued at $3,807,000. Northwestern Mutual Wealth Management Co. grew its stake in Danaher by 303.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after acquiring an additional 186,584 shares in the last quarter. Puzo Michael J purchased a new position in Danaher during the 2nd quarter valued at about $8,624,000. Legal & General Group Plc increased its holdings in shares of Danaher by 1.0% in the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock valued at $1,029,061,000 after purchasing an additional 43,169 shares during the period. Finally, Madison Asset Management LLC purchased a new stake in shares of Danaher in the second quarter worth approximately $85,451,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on DHR. Citigroup started coverage on shares of Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target on the stock. DZ Bank assumed coverage on Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. Wells Fargo & Company decreased their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. HSBC dropped their price objective on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Finally, Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Price Performance

NYSE:DHR opened at $215.74 on Friday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The firm’s 50-day simple moving average is $198.69 and its 200 day simple moving average is $192.35. The firm has a market cap of $151.67 billion, a price-to-earnings ratio of 38.32, a P/E/G ratio of 2.68 and a beta of 0.78.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period last year, the firm earned $0.77 earnings per share. As a group, sell-side analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.